30 related articles for article (PubMed ID: 30907214)
1. First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium.
Dudani S; Graham J; Wells JC; Bakouny Z; Pal SK; Dizman N; Donskov F; Porta C; de Velasco G; Hansen A; Iafolla M; Beuselinck B; Vaishampayan UN; Wood LA; Liow E; Yan F; Yuasa T; Bjarnason GA; Choueiri TK; Heng DYC
Eur Urol; 2019 Dec; 76(6):861-867. PubMed ID: 31445844
[TBL] [Abstract][Full Text] [Related]
2. Patient experience of follow-up after surgery for kidney cancer: a focus group study.
Harrison H; Stewart GD; Usher-Smith JA
BJU Int; 2023 Jul; 132(1):47-55. PubMed ID: 36726216
[TBL] [Abstract][Full Text] [Related]
3. Local Treatment of Recurrent Renal Cell Carcinoma May Have a Significant Survival Effect Across All Risk-of-recurrence Groups.
Marconi L; Kuusk T; Capitanio U; Beisland C; Lam T; Pello SF; Stewart GD; Klatte T; Volpe A; Ljungberg B; Dabestani S; Bex A
Eur Urol Open Sci; 2023 Jan; 47():65-72. PubMed ID: 36601038
[TBL] [Abstract][Full Text] [Related]
4. GRade, Age, Nodes, and Tumor (GRANT) compared with Leibovich score to predict survival in localized renal cell carcinoma: A nationwide study.
Juul S; Donskov F; Clark PE; Lund L; Azawi NH
Int J Urol; 2022 Jul; 29(7):641-645. PubMed ID: 35362146
[TBL] [Abstract][Full Text] [Related]
5. Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study.
Wang Z; Yin Y; Wang J; Zhu Y; Li X; Zeng X
Front Oncol; 2021; 11():716741. PubMed ID: 34395291
[TBL] [Abstract][Full Text] [Related]
6. Oncological Outcomes of Patients With Different Pathological Features of pT3a Renal Tumor: A Systematic Review and Quantitative Synthesis.
Guo P; Wang Y; Han Y; Wei D; Zhao J; Li M; Jiang Y; Luo Y
Front Oncol; 2021; 11():678459. PubMed ID: 34150642
[TBL] [Abstract][Full Text] [Related]
7. Isolated local recurrence of renal cell carcinoma after radical nephrectomy: experience with 10 cases.
Göğüş C; Baltaci S; Bedük Y; Sahinli S; Küpeli S; Göğüş O
Urology; 2003 May; 61(5):926-9. PubMed ID: 12736006
[TBL] [Abstract][Full Text] [Related]
8. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma.
Williamson TJ; Pearson JR; Ischia J; Bolton DM; Lawrentschuk N
BJU Int; 2016 Apr; 117(4):555-62. PubMed ID: 26617405
[TBL] [Abstract][Full Text] [Related]
9. Intensive Imaging-based Follow-up of Surgically Treated Localised Renal Cell Carcinoma Does Not Improve Post-recurrence Survival: Results from a European Multicentre Database (RECUR).
Dabestani S; Beisland C; Stewart GD; Bensalah K; Gudmundsson E; Lam TB; Gietzmann W; Zakikhani P; Marconi L; Fernandéz-Pello S; Monagas S; Williams SP; Torbrand C; Powles T; Van Werkhoven E; Meijer R; Volpe A; Staehler M; Ljungberg B; Bex A
Eur Urol; 2019 Feb; 75(2):261-264. PubMed ID: 30318330
[TBL] [Abstract][Full Text] [Related]
10. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
11. Imaging strategy and outcome following partial nephrectomy.
Mouracade P; Chavali JS; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Rini BI; Kaouk JH
Urol Oncol; 2017 Nov; 35(11):660.e1-660.e8. PubMed ID: 28863862
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma: RECUR Database Analysis.
Dabestani S; Beisland C; Stewart GD; Bensalah K; Gudmundsson E; Lam TB; Gietzmann W; Zakikhani P; Marconi L; Fernandéz-Pello S; Monagas S; Williams SP; Torbrand C; Powles T; Van Werkhoven E; Meijer R; Volpe A; Staehler M; Ljungberg B; Bex A
Eur Urol Focus; 2019 Sep; 5(5):857-866. PubMed ID: 29525381
[TBL] [Abstract][Full Text] [Related]
13. The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol.
Antonelli A; Cozzoli A; Zani D; Zanotelli T; Nicolai M; Cunico SC; Simeone C
BJU Int; 2007 Feb; 99(2):296-300. PubMed ID: 17326263
[TBL] [Abstract][Full Text] [Related]
14. Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.).
Dabestani S; Beisland C; Stewart GD; Bensalah K; Gudmundsson E; Lam TB; Gietzmann W; Zakikhani P; Marconi L; Fernandéz-Pello S; Monagas S; Williams SP; Powles T; Van Werkhoven E; Meijer R; Volpe A; Staehler M; Ljungberg B; Bex A
Scand J Urol; 2019 Feb; 53(1):14-20. PubMed ID: 30907214
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
